IX Biopharma News

IX Biopharma: General Announcement-Update For Shareholders

Mar 20 06:51 ET

IX Biopharma: General Announcement-Press Release - iX Biopharma Announces Development of Semaglutide Sublingual Wafer, iXB 401

Mar 11 05:30 ET

IX Biopharma: General Announcement-Press Release - iX Biopharma Unveils Novel NAD Wafers

Mar 4 04:25 ET

IX Biopharma: General Announcement-Termination Of Wafermine Licensing Agreement

Mar 1 04:20 ET

IX Biopharma: Financial Statements and Related Announcement-Half Yearly Results

Feb 5 05:08 ET

IX Biopharma: Employee Stock Option/ Share Scheme-Grant of Share Awards Pursuant to iX Performance Share Plan

Dec 1, 2023 05:09 ET

IX Biopharma: General Announcement-Notice Of Termination Of Wafermine Licensing Agreement

Nov 17, 2023 09:35 ET

IX Biopharma: General Announcement-Change of Address of Share Registrar and Place Where Register of Members and Index Is Kept

Nov 14, 2023 04:32 ET

IX Biopharma: General Announcement-Minutes of Annual General Meeting Held on 13 October 2023

Nov 10, 2023 04:37 ET

IX Biopharma: REPL-Annual General Meeting-Voluntary

Oct 13, 2023 07:06 ET

IX Biopharma: General Announcement-Responses to Questions from the Securities Investors Association (Singapore)

Oct 11, 2023 19:11 ET

IX Biopharma: General Announcement-Questions & Answers Provided by iX Biopharma Ltd for Annual General Meeting on 13 October 2023

Oct 6, 2023 05:37 ET

IX Biopharma: General Announcement-Corrigenda - Corporate Governance Reports 2022 and 2023

Oct 4, 2023 07:44 ET

IX Biopharma: General Announcement-Press Release - iX Biopharma Introduces MeltMed in USA

Sep 29, 2023 05:23 ET

IX Biopharma: Annual Reports and Related Documents

Sep 25, 2023 19:12 ET

IX Biopharma: Annual General Meeting-Voluntary

Sep 25, 2023 19:11 ET

IX Biopharma: Financial Statements and Related Announcement-Full Yearly Results

Aug 21, 2023 07:34 ET

IX Biopharma: General Announcement-Press Release - iX Biopharma Develops Sublingual Interferon

Aug 15, 2023 19:09 ET

IX Biopharma: General Announcement-Proposed Issuance of Convertible Bonds of An Aggregate Principal Amount of S$2,000,000 - Completion

Jul 24, 2023 09:24 ET

IX Biopharma: General Announcement-Proposed Issuance of Convertible Bonds of S$2,000,000 - Receipt of Listing and Quotation Notice

Jul 17, 2023 07:07 ET